Ignite Creation Date:
2024-07-17 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06472778
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-06-19
Brief Title:
A Real-world Study in Participants With Smoldering Multiple Myeloma
Sponsor:
Janssen-Cilag Ltd
Organization:
Janssen-Cilag Ltd
Study Overview
Official Title:
Smoldering Pathway Assessment Real-World Knowledge SPARK Study-Retrospective Observational Non-interventional Chart Review Study in Smoldering Multiple Myeloma
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the real-world characteristics and outcomes of participants with smoldering multiple myeloma SMM overall and by high-risk and non-high-risk SMM according to AQUILA study criteria NCT03301220 Mayo 20-2-20 and international myeloma working group IMWG 2020 risk classification models and to evaluate the risk of progressing of SMM to multiple myeloma MM and outcomes in participants after progressing to MM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None